Menstrual Phase Effects on Exercise Physiology: Clinical and Scientific Review

Abstract

Understanding the influence of menstrual cycle phases on exercise physiology is crucial for optimizing training regimens and clinical care for menstruating individuals. This review synthesizes current evidence on the physiological, hormonal, and metabolic variations across menstrual phases and their impact on exercise performance, risk of injury, and recovery. We discuss prevalence, underlying mechanisms, risk stratification, clinical manifestations, diagnostic approaches, and evidence-based management, integrating recent advances and guideline recommendations to inform best practices for healthcare professionals.

Introduction

The menstrual cycle, characterized by predictable hormonal fluctuations, exerts significant effects on multiple physiological systems. Increasing recognition of these effects has prompted investigation into their implications for exercise tolerance, performance, and rehabilitation. For clinicians and exercise scientists, a nuanced understanding of menstrual phase-dependent variations is essential for individualized care, injury prevention, and optimization of physical training among menstruating athletes and patients.

Epidemiology / Disease Burden

An estimated 1.8 billion individuals worldwide experience menstruation, with a growing proportion actively participating in sports and physical training at amateur and professional levels. Menstrual phase-related symptoms impact up to 80% of menstruating individuals, with nearly half reporting changes in exercise performance or tolerance during the cycle. The clinical relevance extends to increased injury rates, altered musculoskeletal function, and fluctuating cardiorespiratory capacity, highlighting the need for awareness and individualized management.

Pathophysiology

The menstrual cycle comprises the follicular, ovulatory, and luteal phases, each orchestrated by dynamic fluctuations in estrogen and progesterone. These hormones modulate cardiovascular, respiratory, thermoregulatory, and neuromuscular systems. Estrogen enhances vasodilation, substrate utilization, and muscle recovery, while progesterone influences ventilatory drive, fluid balance, and thermogenesis. The luteal phase, characterized by elevated progesterone, is associated with increased core temperature, reduced plasma volume, and altered substrate metabolism, potentially impairing endurance and increasing perceived exertion.

Risk Factors

Risk modifiers for adverse exercise responses during menstruation include high training loads, low energy availability, prior history of dysmenorrhea or premenstrual syndrome, polycystic ovary syndrome (PCOS), and use of hormonal contraceptives. Athletes with irregular cycles or eating disorders, such as those with the Female Athlete Triad or Relative Energy Deficiency in Sport (RED-S), are particularly susceptible to menstrual-related exercise impairments and injury risks.

Clinical Features

Symptoms vary widely but commonly include fatigue, diminished performance, altered mood, increased perceived exertion, and musculoskeletal complaints. The late luteal and early follicular phases, often associated with significant hormonal shifts and menstrual bleeding, correlate with increased reports of cramping, reduced endurance, and higher injury incidence—particularly anterior cruciate ligament (ACL) injuries in female athletes. Some individuals also report improved performance during the mid-follicular phase, when estrogen peaks and progesterone remains low.

Diagnosis

Diagnosis of menstrual phase effects on exercise relies on detailed menstrual history, symptom tracking, and correlation with training logs. Cycle tracking tools and hormonal assays can aid in phase identification and pattern recognition. Differential diagnoses include underlying gynecological conditions (e.g., endometriosis, PCOS), thyroid dysfunction, and stress-related amenorrhea, necessitating a comprehensive evaluation in athletes with abnormal cycles or persistent symptoms.

Treatment & Management

Management strategies include individualized training modifications based on symptom burden and phase, non-pharmacological interventions such as nutritional optimization and hydration, and pharmacologic treatments for severe symptoms. Non-steroidal anti-inflammatory drugs (NSAIDs) may alleviate dysmenorrhea, while hormonal contraceptives can stabilize cycles and mitigate symptom variability, though their impact on performance remains variable. Patient education and multidisciplinary care, integrating gynecologists, sports physicians, and nutritionists, are paramount.

Recent Advances / Emerging Therapies

Recent studies leverage wearable technology and real-time biomarker monitoring to map physiological changes across the cycle, enabling more precise phase-based training adjustments. Emerging therapies include targeted hormonal modulation and menstrual cycle-informed rehabilitation protocols. Novel research explores the gut microbiome, inflammatory markers, and genetic determinants influencing exercise responses during menstruation, promising more personalized approaches in the near future.

Guideline Recommendations

Leading bodies such as the American College of Sports Medicine (ACSM) and International Olympic Committee (IOC) recommend routine assessment of menstrual health in physically active individuals, with emphasis on individualized care and regular monitoring. Guidelines advocate for menstrual cycle tracking, patient education, and adaptation of training loads in response to symptomatology. Pharmacological intervention should be considered for refractory symptoms, with shared decision-making central to management planning.

Conclusion

The menstrual cycle intricately modulates exercise physiology through hormonal, metabolic, and neuromuscular pathways. Awareness of phase-dependent variations is essential for clinicians and trainers to optimize performance, minimize injury risk, and support the well-being of menstruating individuals. Ongoing research and guideline-based practice will continue to refine individualized approaches, ensuring safe and effective physical activity participation across the menstrual lifespan.